(Q40705863)

22 September 2017

title

A gene therapy for cancer based on the angiogenesis inhibitor, vasostatin (English)

1 reference

22 September 2017

0 references

angiogenesis inhibitor

1 reference

Xiao F

1

1 reference

22 September 2017

Wei Y

2

1 reference

22 September 2017

Yang L

3

1 reference

22 September 2017

Zhao X

4

1 reference

22 September 2017

Tian L

5

1 reference

22 September 2017

Ding Z

6

1 reference

22 September 2017

Yuan S

7

1 reference

22 September 2017

Lou Y

8

1 reference

22 September 2017

Liu F

9

1 reference

22 September 2017

Wen Y

10

1 reference

22 September 2017

Li J

11

1 reference

22 September 2017

Deng H

12

1 reference

22 September 2017

Kang B

13

1 reference

22 September 2017

Mao Y

14

1 reference

22 September 2017

Lei S

15

1 reference

22 September 2017

He Q

16

1 reference

22 September 2017

Su J

17

1 reference

22 September 2017

Lu Y

18

1 reference

22 September 2017

Niu T

19

1 reference

22 September 2017

Hou J

20

1 reference

22 September 2017

Huang MJ

21

1 reference

22 September 2017

publication date

1 September 2002

1 reference

22 September 2017

1 reference

22 September 2017

volume

9

1 reference

22 September 2017

issue

18

1 reference

22 September 2017

page(s)

1207-1213

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301788

22 September 2017

exact match

0 references

cites work

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

The rationale and future potential of angiogenesis inhibitors in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Clinical applications of angiogenic growth factors and their inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Systemic gene therapy with anti-angiogenic factors inhibits spontaneous breast tumor growth and metastasis in MMTVneu transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Suppression of angiogenesis and tumor growth by the inhibitor K1-5 generated by plasmin-mediated proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Vasostatin, a calreticulin fragment, inhibits angiogenesis and suppresses tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

A gene therapy for cancer using intramuscular injection of plasmid DNA encoding interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Gene therapy for cancer: what have we done and where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Gene therapy safety issues come to fore

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Non-viral vectors in cancer gene therapy: principles and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Non-viral approaches to gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Immunogene therapy of tumors with vaccine based on Xenopus homologous vascular endothelial growth factor as a model antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

A mutant form of vascular endothelial growth factor (VEGF) that lacks VEGF receptor-2 activation retains the ability to induce vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

In situ observation of inflammatory cell-tumor cell interaction in human seminomas (germinomas): light, electron microscopic, and immunohistochemical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

A cancer therapy resistant to resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

…as Rockefeller head warns of backlash

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

Transplacental carcinogenesis by stilbestrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

7 January 2021

Immunotherapy of tumors with xenogeneic endothelial cells as a vaccine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

7 January 2021

Inhibition of development of murine melanoma lung metastases by systemic administration of recombinant platelet factor 4

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

7 January 2021

Immunogene therapy of tumors with a vaccine based on the ligand-binding domain of chicken homologous integrin beta3

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

7 January 2021

Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301788

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301788

1 reference

Dimensions Publication ID

22 September 2017

1040644216

0 references

1 reference